Literature DB >> 2322576

Intracellular fate of fibrinogen B beta chain expressed in COS cells.

K Danishefsky1, R Hartwig, D Banerjee, C Redman.   

Abstract

Full-length fibrinogen B beta cDNA was subcloned into an expression vector, pBC12BI, and transfected into COS cells. B beta chain expression was measured by pulse-labelling cells with L-[35S]methionine, immunoprecipitating the B beta chain with antibody to fibrinogen and separating the nascent radioactive protein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). B beta chain was expressed in transfected COS cells but was not secreted into the medium. Treatment with endoglycosidase H showed that non-secreted B beta chain contains mannose-rich carbohydrates rather than the complex form of carbohydrate which occurs in plasma fibrinogen and indicates that B beta chain is not transported to the Golgi apparatus. In transfected COS cells, antibody to fibrinogen co-immunoprecipitated B beta chain and 78 kDa immunoglobulin-binding protein (BiP) and antibody to BiP immunoprecipitated BiP and nascent B beta chains. Non-secreted B beta chain was degraded intracellularly with a half-life of 5 h by enzymes which were not affected by incubating transfected cells with NH4Cl, which indicates a non-lysosomal pathway of degradation. These studies indicate that B beta chain by itself does not contain the signal for fibrinogen secretion and that non-secreted B beta chain is associated with BiP and degraded in the rough endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2322576     DOI: 10.1016/0167-4781(90)90057-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Secretion of recombinant human fibrinogen by the murine mammary gland.

Authors:  Stephen P Butler; Tanya K O'Sickey; Susan T Lord; Henryk Lubon; Francis C Gwazdauskas; William H Velander
Journal:  Transgenic Res       Date:  2004-10       Impact factor: 2.788

2.  Selective protein degradation in the yeast exocytic pathway.

Authors:  A A McCracken; K B Kruse
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.